QTRX

Quanterix has pioneered ultra-sensitive biomarker detection using its proprietary Simoa (Single Molecule Array) technology. The platform enables measurement of proteins at extremely low concentrations in blood, advancing early disease detection, drug development, and precision medicine. Quanterix serves pharmaceutical, clinical research, and diagnostic markets with instruments, consumables, and testing services.